FierceBiotech Dec 23, 2025 Edwards nets FDA approval for Sapien M3 transcatheter mitral valve replacement
FierceBiotech Dec 23, 2025 Windtree offloads cardio pipeline, Vaccinex secures $60M funding in continued holiday shopping spree
FierceBiotech Dec 23, 2025 Despite geopolitical pressures, China biotech deals remain at pace as collective value soars: Evaluate
FierceBiotech Dec 23, 2025 Hope springs toward Parkinson's phase 3 despite divergent stem cell therapy data
FierceBiotech Dec 23, 2025 Miracle babies, antibiotic improv and T-cell tamers: Fierce's favorite research stories of 2025
FierceBiotech Dec 22, 2025 BioMarin quietly discards liver disease candidate after $4.8B Amicus announcement
FierceBiotech Dec 22, 2025 Boehringer spells out a $448M future for Rectify's ABC kidney disease program
FierceBiotech Dec 22, 2025 Editor's corner: Fierce Medtech's top 10 stories of 2025 show how tech can treat
FierceBiotech Dec 22, 2025 AstraZeneca flunks phase 3 lung cancer test in further setback to synthetic lethal mechanism
FierceBiotech Dec 20, 2025 Looking ahead with BD’s Bilal Muhsin on what good AI can still do for healthcare